10-133186078-G-A
Variant summary
Our verdict is Benign. Variant got -10 ACMG points: 0P and 10B. BP4_StrongBP6_ModerateBS2
The ENST00000304613.8(KNDC1):c.730G>A(p.Glu244Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000519 in 1,598,586 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. E244Q) has been classified as Uncertain significance.
Frequency
Consequence
ENST00000304613.8 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -10 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
KNDC1 | NM_152643.8 | c.730G>A | p.Glu244Lys | missense_variant | 6/30 | ENST00000304613.8 | NP_689856.6 | |
KNDC1 | XM_017016858.3 | c.730G>A | p.Glu244Lys | missense_variant | 6/27 | XP_016872347.1 | ||
KNDC1 | XM_017016859.3 | c.730G>A | p.Glu244Lys | missense_variant | 6/21 | XP_016872348.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
KNDC1 | ENST00000304613.8 | c.730G>A | p.Glu244Lys | missense_variant | 6/30 | 1 | NM_152643.8 | ENSP00000304437.3 |
Frequencies
GnomAD3 genomes AF: 0.0000461 AC: 7AN: 151914Hom.: 0 Cov.: 30
GnomAD3 exomes AF: 0.0000806 AC: 17AN: 210816Hom.: 1 AF XY: 0.000112 AC XY: 13AN XY: 116198
GnomAD4 exome AF: 0.0000525 AC: 76AN: 1446672Hom.: 2 Cov.: 35 AF XY: 0.0000682 AC XY: 49AN XY: 718286
GnomAD4 genome AF: 0.0000461 AC: 7AN: 151914Hom.: 0 Cov.: 30 AF XY: 0.0000539 AC XY: 4AN XY: 74200
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 10, 2023 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at